Pages that link to "Q53473244"
Jump to navigation
Jump to search
The following pages link to Early de novo ovarian carcinoma. A study of fourteen cases. (Q53473244):
Displaying 50 items.
- Recent concepts of ovarian carcinogenesis: type I and type II (Q27009487) (← links)
- Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence (Q30250107) (← links)
- Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification (Q31141440) (← links)
- The preclinical natural history of serous ovarian cancer: defining the target for early detection (Q33487678) (← links)
- The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube (Q33510967) (← links)
- Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells (Q33521103) (← links)
- Genetic analysis of the early natural history of epithelial ovarian carcinoma (Q33570452) (← links)
- The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory (Q33739695) (← links)
- The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation (Q34029565) (← links)
- Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects (Q34033619) (← links)
- Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube. (Q34201837) (← links)
- Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO. (Q34473693) (← links)
- Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer. (Q34669870) (← links)
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations (Q34761925) (← links)
- Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations (Q34811314) (← links)
- Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems (Q34998994) (← links)
- Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis (Q35098091) (← links)
- Epithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions. (Q35116928) (← links)
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm (Q35140600) (← links)
- Pathology of ovarian carcinoma (Q35213220) (← links)
- Oncolytic virotherapy for ovarian cancer (Q35597082) (← links)
- Ovarian cancer: opportunity for targeted therapy (Q35659945) (← links)
- Potential for TRAIL as a therapeutic agent in ovarian cancer (Q35756907) (← links)
- Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. (Q35758403) (← links)
- beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome (Q35787682) (← links)
- Diverse tumorigenic pathways in ovarian serous carcinoma (Q35789009) (← links)
- Ovarian Cancer Is an Imported Disease: Fact or Fiction? (Q35878320) (← links)
- Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis (Q35983656) (← links)
- Are germinal inclusion cysts markers of ovulation? (Q36015297) (← links)
- Origins and molecular pathology of ovarian cancer (Q36068263) (← links)
- Induction of ovarian cancer by defined multiple genetic changes in a mouse model system (Q36496578) (← links)
- Technical challenges and limitations of current mouse models of ovarian cancer (Q36510070) (← links)
- Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression (Q36621237) (← links)
- Characterisation of human kallikrein 6/protease M expression in ovarian cancer (Q36626102) (← links)
- Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression (Q36661649) (← links)
- Preventing ovarian cancer by salpingectomy. (Q36897728) (← links)
- The duplicitous origin of ovarian cancer (Q36919484) (← links)
- Contemporary progress in ovarian cancer screening (Q36996793) (← links)
- Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma. (Q37029695) (← links)
- Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications (Q37101060) (← links)
- PAX8 expression in ovarian surface epithelial cells (Q37109448) (← links)
- New insights into the pathogenesis of serous ovarian cancer and its clinical impact (Q37119411) (← links)
- A serum based analysis of ovarian epithelial tumorigenesis (Q37133800) (← links)
- Molecular pathogenesis of endometrial and ovarian cancer (Q37293672) (← links)
- Precursors of endometrial and ovarian carcinoma (Q37622105) (← links)
- Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis (Q37676705) (← links)
- Molecular characterization of ovarian cancer by gene-expression profiling. (Q37741508) (← links)
- Characterization and comparison of precursors of ovarian and endometrial carcinoma: parts I and II. (Q37756401) (← links)
- Hereditary gynaecological malignancies: advances in screening and treatment (Q38067433) (← links)
- Development of a mouse model of menopausal ovarian cancer (Q38195046) (← links)